Borsat Al Khaleej Live Support
Leave a message and our representative will contact you soon
15/08/2025 13:46 AST
Gulf Pharmaceutical Industries (Julphar) has reported a steady revenue growth, an expansion in operating profits, and an improvement in its financial position during the second quarter and first half of the year.
In the first half of 2025, Julphar achieved net revenues of AED707.3 million ($192.57 million), a growth of 4.7% (5.8% at constant prices). Gross profit increased to AED298 million, a growth of 12.8%. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) grew by 27.9% to AED91.6 million, with the profit margin increasing from 10.6% to 13.0%.
Net profit also rose from AED7.3 million to AED38.6 million, while total net profit reached AED158.2 million, including an exceptional capital gain of AED118.7 million from the sale of Zahrat Al Rawda Pharmacies Company, Julphar said.
Sheikh Saqr bin Humaid bin Abdullah Al Qasimi, Chairman of the Board of Directors of Julphar, stated: "Julphar's performance in the first six months of 2025 represents a pivotal step forward, with strong revenue growth and continuous progress in our strategic priorities. These results reflect our commitment to operational excellence and our teams' ability to achieve ambitious goals. With the launch of new products and market expansion, we are solidifying our position as a leading healthcare partner in the Gulf and beyond."
Trade Arabia
14/08/2026
Gulf Pharmaceutical Industries PSC (Julphar) on Thursday reported that revenue from continuing operations increased to Dh573.7 million, compared to Dh547.9 million in H1 2025, representing year-on-ye
Khaleej Times
20/05/2025
Gulf Pharmaceutical Industries (Julphar) plans to invest Dh300 million over the next five years to expand its manufacturing base and localise advanced pharmaceutical technologies, CEO Basel Ziyadeh c
Gulfnews
04/04/2018
Julphar, a leading pharmaceutical manufacturer in the region, has been ranked as the number one pharmaceutical company in the UAE by IMS Health February 2018 panel, reflecting a strong double digit s
Trade Arabia
| Ticker | Price | Volume |
|---|
| Ticker | Price | Change |
|---|---|---|
| PUREHEALTH | 2.52 | -0.03 (-1.18 |
| BURJEEL | 1.25 | 0.00 (0.00 |
| MIDAN | 930.00 | -41.00 (-4.23 |
| GMPC | 2.37 | 0.09 (3.94 |
| ATC.KW | 545.00 | -1.00 (-0.19 |
21/08/2026
Saudi Arabian Refineries Company (SARCO) has announced that its key subsidiary Raya Al Tajdeed has secured a SAR100 million ($26.7 million) contract from a multinational education company for the con
Trade Arabia
21/08/2026
Saudi Awwal Bank, one of the leading banks in the Kingdom of Saudi Arabia, has partnered with noon, one of the region's leading e-commerce platforms, to launch a first-of-its-kind co-branded Visa cre
Saudi Gazette
21/08/2026
United Foods Company (UFC), a leading UAE-based food manufacturing and distribution company, reported a strong performance for the second quarter of 2026, reflecting continued growth in business acti
Trade Arabia
21/08/2026
Saudi Air Connectivity Program (ACP), in collaboration with Saudia, has announced an increase in seat capacity across several international routes in 2026.
This step reflects ongoing effort
Trade Arabia
20/08/2026
Arabian Centers Company (Cenomi Centers), a leading Saudi developer of lifestyle destinations, has signed a promise-to-lease agreement with Saudi Downtown Company, a Public Investment Fund (PIF) comp
Trade Arabia